Producción CyT
FSH and Sertoli cell biomarkers accurately distinguish hypogonadotropic hypogonadism from self-limited delayed puberty

Artículo

Autoría
Castro, Sebastián ; Correa Brito, Lourdes ; Bedecarrás, Patricia ; Ballerini, María Gabriela ; Sansó, Gabriela ; Keselman, Ana ; Cassinelli, Hamilton ; Arcari, Andrea Josefina ; Alonso, Guillermo F ; Chan, Yee-Ming ; He, Wen ; Ropelato, María Gabriela ; Bergadá, Ignacio ; Cassorla, Fernando ; Rey, Rodolfo A ; GRINSPON, ROMINA
Fecha
2025
Editorial y Lugar de Edición
ENDOCRINE SOC
Revista
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM ENDOCRINE SOC
Resumen Información suministrada por el agente en SIGEVA
Context: Delayed puberty is a frequent complaint in males. The differential diagnosis between self-8 limited delayed puberty (SLDP) and congenital hypogonadotropic hypogonadism (CHH) is 9 challenging. Commonly used endocrine tests, focusing on stimulated levels of luteinizing hormone 10 (LH) or testosterone, are not satisfactory in making a diagnosis. Because FSH action on Sertoli 11 cells results in testis enlargement and anti-Müllerian hormone (AMH) and inhibin B increased 12 secretion, ... Context: Delayed puberty is a frequent complaint in males. The differential diagnosis between self-8 limited delayed puberty (SLDP) and congenital hypogonadotropic hypogonadism (CHH) is 9 challenging. Commonly used endocrine tests, focusing on stimulated levels of luteinizing hormone 10 (LH) or testosterone, are not satisfactory in making a diagnosis. Because FSH action on Sertoli 11 cells results in testis enlargement and anti-Müllerian hormone (AMH) and inhibin B increased 12 secretion, and the FSH-Sertoli cell axis function is detectable during normal childhood and early 13 puberty, we tested whether the assessment of serum FSH, AMH and inhibin B would be informative 14 to distinguish between SLDP and CHH. 15 Design: We performed a prospective, nested case-control study, in a cohort of male adolescents 16 presenting with delayed puberty, comparing baseline serum reproductive hormone levels to 17 identify predictive biomarkers of CHH, after having followed all participants prospectively until a 18 final diagnosis was ascertained based on gold standard criteria (age 18 years or ≥4 years after 19 testis volume reached 4 mL). 20 Results: Of 65 participants who completed follow-up, 33 had a final diagnosis of SLDP and 32 of 21 CHH. Serum FSH, AMH and inhibin B showed better diagnostic efficiency than LH and 22 testosterone for these differential diagnoses. FSH (IU/L) x inhibin B (ng/mL) <92 and FSH (IU/L) x 23 AMH (pmol/L) <537 showed high sensitivity (>93%), specificity (≥92%), predictive values (>92%) 24 and positive likelihood ratio (>12) for CHH. The diagnostic performance remained 89.7% and 25 88.2% for FSH x inhibin B and FSH x AMH, respectively, when analyzed in patients without red 26 flags (micropenis, cryptorchidism and/or microorchidism). 27 Conclusions: Serum FSH combined with inhibin B or AMH is highly predictive to accurately 28 distinguish between SLDP and CHH in adolescent males.
Ver más Ver menos
Palabras Clave
AMHself-limited 30 delayed pubertyFSHcongenital hypogonadotropic hypogonadism